Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate …
SJ Kim, H Uehara, T Karashima, DL Shepherd… - Clinical cancer …, 2003 - AACR
Purpose: We determined whether blockade of the epidermal growth factor receptor (EGF-R)
signaling pathway by oral administration of the EGF-R tyrosine kinase inhibitor (PKI 166) …
signaling pathway by oral administration of the EGF-R tyrosine kinase inhibitor (PKI 166) …
Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate …
SJ Kim, H Uehara, T Karashima… - … Cancer Research: an …, 2003 - europepmc.org
Purpose We determined whether blockade of the epidermal growth factor receptor (EGF-R)
signaling pathway by oral administration of the EGF-R tyrosine kinase inhibitor (PKI 166) …
signaling pathway by oral administration of the EGF-R tyrosine kinase inhibitor (PKI 166) …
Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate …
SJ Kim, H Uehara, T Karashima… - … : an official journal …, 2003 - pubmed.ncbi.nlm.nih.gov
Purpose We determined whether blockade of the epidermal growth factor receptor (EGF-R)
signaling pathway by oral administration of the EGF-R tyrosine kinase inhibitor (PKI 166) …
signaling pathway by oral administration of the EGF-R tyrosine kinase inhibitor (PKI 166) …
[引用][C] Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human …
SJ KIM, H UEHARA, T KARASHIMA… - Clinical cancer …, 2003 - pascal-francis.inist.fr
Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated
endothelial cells for therapy of androgen-independent human prostate cancer growing in …
endothelial cells for therapy of androgen-independent human prostate cancer growing in …
Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate …
SJ Kim, H Uehara, T Karashima… - Clinical Cancer …, 2003 - hero.epa.gov
PURPOSE: We determined whether blockade of the epidermal growth factor receptor (EGF-
R) signaling pathway by oral administration of the EGF-R tyrosine kinase inhibitor (PKI 166) …
R) signaling pathway by oral administration of the EGF-R tyrosine kinase inhibitor (PKI 166) …
[引用][C] Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human …
KIM SJ - Clin Cancer Res, 2003 - cir.nii.ac.jp
Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated
endothelial cells for therapy of androgen-independent human prostate cancer growing in the …
endothelial cells for therapy of androgen-independent human prostate cancer growing in the …
Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate …
SJ Kim, H Uehara, T Karashima… - Clinical Cancer …, 2003 - mdanderson.elsevierpure.com
Purpose: We determined whether blockade of the epidermal growth factor receptor (EGF-R)
signaling pathway by oral administration of the EGF-R tyrosine kinase inhibitor (PKI 166) …
signaling pathway by oral administration of the EGF-R tyrosine kinase inhibitor (PKI 166) …
[引用][C] Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human …
KIM SJ - Clin Cancer Res, 2003 - cir.nii.ac.jp
Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated
endothelial cells for therapy of androgen-independent human prostate cancer growing in the …
endothelial cells for therapy of androgen-independent human prostate cancer growing in the …